Discovery of novel 4-arylamino-quinazoline derivatives as EGFRL858R/T790M inhibitors with the potential to inhibit the non-small cell lung cancers - Concepedia

Concepedia

Publication | Closed Access

Discovery of novel 4-arylamino-quinazoline derivatives as EGFRL858R/T790M inhibitors with the potential to inhibit the non-small cell lung cancers

13

Citations

23

References

2022

Year

Wenhui Gan, Caolin Wang, Qingshan Pan, Yuzhen Li, Yuping Guo, Dang Fan, Yuting Peng, Zixuan Rao, Shan Xu, Pengwu Zheng,

Bioorganic Chemistry

Medicinal ChemistryEgfrl858r/t790m InhibitorsMedicineBronchial NeoplasmPharmacotherapyAnti-cancer AgentNovel 4-Arylamino-quinazoline DerivativesDrug DevelopmentPharmacologyRadiation OncologyLung CancerDrug Discovery

References

	Year	Citations

Page 1

Page 1